Key result
Low-dose caffeine tablets improve cognitive response rates and prevent sleepiness during nap deprivation.
Why the study?
Do low-dose caffeine oral tablets improve mental fatigue and cognitive performance induced by nap deprivation in healthy volunteers?
Do low-dose caffeine oral tablets improve mental fatigue and cognitive performance induced by nap deprivation in healthy volunteers?
Low-dose caffeine oral tablets may mitigate subjective fatigue and cognitive decline induced by nap deprivation, though larger randomized trials are needed.
Answers are grounded in this paper and cite their sources.
Low-dose caffeine may mitigate nap-deprivation fatigue and cognitive decline in healthy adults; extends prior data but requires larger trials for confirmation.
Background This study aimed to investigate the feasibility of inducing mental fatigue (MF) through nap deprivation, based on monitoring heart rate variability (HRV), cognitive performance, and subjective fatigue levels. Additionally, the intervention effect of caffeine oral tablets (COT) on MF was evaluated. Methods This was an open-label, non-randomized, single-sequence crossover pilot study. The caffeine content in COT was quantified using high-performance liquid chromatography (HPLC). Ten healthy volunteers who habitually took naps were enrolled. Participants underwent nap deprivation to induce MF. Various parameters were collected at different time points, including the Karolinska Sleepiness Scale (KSS), Attention Network Task (ANT), and HRV metrics. Changes in each parameter before and after COT intervention were analyzed. Results Following nap deprivation, there was a significant increase in KSS scores for the control group compared to baseline measurements taken after 2 h of sleep deprivation ( P < 0.01). No significant changes were observed in ANT performance; however, HRV exhibited variations influenced by circadian rhythms—showing increased volatility in time-domain parameters and differing trends in frequency-domain parameters without statistical significance. After administration of low-dose COT to experimental participants, KSS scores did not significantly rise; conversely, correct response rates (CR) on ANT improved significantly ( P < 0.05), alongside notable changes in both time-domain and frequency-domain HRV parameters ( P < 0.05). Conclusions In this pilot study, the alignment between subjective and objective indices suggests that low-dose COT is associated with favorable changes in the MF state of volunteers following sleep deprivation. However, due to the small sample size and open-label design, these findings should be considered preliminary and warrant confirmation in larger, randomized controlled trials.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2026) studied Mental fatigue induced by nap deprivation (n=10). Caffeine oral tablets vs. Blank control (no tablet) was evaluated on Mental fatigue assessed by Karolinska Sleepiness Scale (KSS) and Attention Network Task (ANT) correct response rate (p=<0.05). Low-dose caffeine oral tablets (96 mg) significantly improved correct response rates on cognitive tasks (p<0.05) and prevented significant increases in subjective sleepiness during nap deprivation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: